Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment

Author(s):
Swen, J.J.; Guchelaar, H.J. (0000-0002-7085-1383); Baak-Pablo, R.F.; Assendelft, W.J.J.; Wessels, J.A.M.
Published
2011
Publication type
Article / Letter to editor
glibenclamidegliclazideglimepiridepharmacogeneticssulfonylureastolbutamidetype 2 diabetes mellitus
Date issued
2011-08-31
Language
English
Is part of
Pharmacogenetics and Genomics (2011), Vol. 21, no. 8, p. 461-468
hdl
1887/118268
doi
10.1097/FPC.0b013e3283478173